Novel Drug, First Tx Approved for Rare Uveal Melanoma Novel Drug, First Tx Approved for Rare Uveal Melanoma
A novel drug, the first in its class, is also the first treatment approved for use in uveal melanoma, a rare cancer of the eye, after it was shown to improve overall survival.FDA Approvals
Source: Medscape Ophthalmology Headlines - Category: Opthalmology Tags: Hematology-Oncology News Alert Source Type: news
More News: Cancer | Cancer & Oncology | Eye Cancers | Hematology | Melanoma | Opthalmology | Skin Cancer | Uveal Melanoma